Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Grigori Okoev"'
Autor:
Najla El Jurdi, Heba Elhusseini, Joan Beckman, Todd E. DeFor, Grigori Okoev, John Rogosheske, Aleksandr Lazaryan, Kristen Weiler, Veronika Bachanova, Brian C. Betts, Bruce R. Blazar, Claudio G. Brunstein, Fiona He, Shernan G. Holtan, Murali Janakiram, Radhika Gangaraju, Joseph Maakaron, Margaret L. MacMillan, Armin Rashidi, Erica D. Warlick, Smita Bhatia, Gregory Vercellotti, Daniel J. Weisdorf, Mukta Arora
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 5, Pp 1-7 (2021)
Key points Patients with chronic GVHD after allogeneic hematopoietic cell transplantation are at high risk for thromboembolic events occurring years after diagnosis. More severe chronic GVHD, non-O donor-recipient ABO compared to O-O match and person
Externí odkaz:
https://doaj.org/article/271f0e7337a541dbb1020ddc785fbb6c
Autor:
Rajeev Shrimali, Shamim Ahmad, Zuzana Berrong, Grigori Okoev, Adelaida Matevosyan, Ghazaleh Shoja E. Razavi, Robert Petit, Seema Gupta, Mikayel Mkrtichyan, Samir N. Khleif
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-9 (2017)
Abstract Background We previously demonstrated that in addition to generating an antigen-specific immune response, Listeria monocytogenes (Lm)-based immunotherapy significantly reduces the ratio of regulatory T cells (Tregs)/CD4+ and myeloid-derived
Externí odkaz:
https://doaj.org/article/61811cabb1744d598da3309ba03659cc
Autor:
Najla El Jurdi, Grigori Okoev, Todd E. DeFor, Shernan G. Holtan, Brian C. Betts, Bruce R. Blazar, Claudio G. Brunstein, Margaret L. MacMillan, Daniel J. Weisdorf, Mukta Arora
Publikováno v:
Bone Marrow Transplantation. 57:790-794
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::feb2f5eaa6fb365adc83747471f2a891
https://doi.org/10.1038/s41409-022-01628-3
https://doi.org/10.1038/s41409-022-01628-3
Autor:
Todd E. DeFor, Grigori Okoev, Brian C. Betts, Mukta Arora, John E. Wagner, Veronika Bachanova, Claudio G. Brunstein, Armin Rashidi, Margaret L. MacMillan, Takuto Takahashi, Aleksandr Lazaryan, Najla El Jurdi, Erica D. Warlick, Bruce R. Blazar, Daniel J. Weisdorf, Shernan G. Holtan
Publikováno v:
Bone Marrow Transplant
We compared chronic graft-versus-host disease (cGvHD) following umbilical cord blood (UCBT) and matched sibling donor peripheral blood transplant (MSD). 145 patients (2010–2017) with cGvHD after MSD (n = 104) and UCBT (n = 41) were included. Prior
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfe0c9213dc390e3fb01a2e9507e56c0
https://doi.org/10.1038/s41409-020-01195-5
https://doi.org/10.1038/s41409-020-01195-5
Autor:
Najla, El Jurdi, Grigori, Okoev, Todd E, DeFor, Shernan G, Holtan, Brian C, Betts, Bruce R, Blazar, Claudio G, Brunstein, Margaret L, MacMillan, Daniel J, Weisdorf, Mukta, Arora
Publikováno v:
Bone marrow transplantation. 57(5)
Chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic cell transplantation (HCT) requires prolonged immunosuppressive therapy (IST), often requiring slow tapering with patients experiencing cGVHD flares and treatment failure. In 14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc08d51bcda8ee04e07951e5449878f0
https://pubmed.ncbi.nlm.nih.gov/35249105
https://pubmed.ncbi.nlm.nih.gov/35249105
Autor:
Margaret L. MacMillan, Radhika Gangaraju, Najla El Jurdi, Bruce R. Blazar, Kristen Weiler, Murali Janakiram, Mukta Arora, Brian C. Betts, Daniel J. Weisdorf, Gregory M. Vercellotti, Grigori Okoev, Claudio G. Brunstein, Joseph Maakaron, Veronika Bachanova, Heba Elhusseini, Aleksandr Lazaryan, John Rogosheske, Fiona He, Joan D. Beckman, Erica D. Warlick, Armin Rashidi, Shernan G. Holtan, Smita Bhatia, Todd E. DeFor
Publikováno v:
Blood. 136:44-46
Background: Limited studies report a wide range of venous thromboembolism (VTE) incidence among allogeneic hematopoietic cell transplant (alloHCT) recipients. Chronic GVHD (cGVHD) is an immune mediated complication after alloHCT associated with vascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d920f6b690bbd5096255aecf3dce1d17
https://doi.org/10.1182/blood-2020-136337
https://doi.org/10.1182/blood-2020-136337
Autor:
Erica D. Warlick, Armin Rashidi, Smita Bhatia, Murali Janakiram, Aleksandr Lazaryan, Margaret L. MacMillan, Fiona He, Gregory M. Vercellotti, Claudio G. Brunstein, Najla El Jurdi, Todd E. DeFor, Brian C. Betts, Bruce R. Blazar, Heba Elhusseini, Joan D. Beckman, Mukta Arora, Veronika Bachanova, Grigori Okoev, Joseph Maakaron, Shernan G. Holtan, Daniel J. Weisdorf, Radhika Gangaraju, John Rogosheske, Kristen Weiler
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 11, Iss 5, Pp 1-7 (2021)
Blood Cancer Journal, Vol 11, Iss 5, Pp 1-7 (2021)
Chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic cell transplantation (HCT) is associated with systemic inflammation and endothelial dysfunction, increasing risk for thromboembolic events (TEE). In 145 adult recipients who dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1423e9e32cfec6aed4e8e4499b9e8d7
http://europepmc.org/articles/PMC8131386
http://europepmc.org/articles/PMC8131386
Autor:
Takuto Takahashi, Margaret L. MacMillan, Todd E. DeFor, Grigori Okoev, Daniel J. Weisdorf, Mukta Arora
Publikováno v:
Transplantation and cellular therapy. 27(8)
Although acute graft-versus-host disease (aGVHD) and chronic GVHD (cGVHD) are known causes of morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT), the syndrome of late aGVHD is less well understood, particularly in child
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf3be1bf926ed7eea074098b44f9e9a7
https://pubmed.ncbi.nlm.nih.gov/34077812
https://pubmed.ncbi.nlm.nih.gov/34077812
Autor:
Grigori Okoev, Claudio G. Brunstein, Erica D. Warlick, John E. Wagner, Brian C. Betts, Veronika Bachanova, Najla El Jurdi, Shernan G. Holtan, Bruce R. Blazar, Margaret L. MacMillan, Armin Rashidi, Todd E. DeFor, Takuto Takahashi, Aleksandr Lazaryan, Daniel J. Weisdorf, Mukta Arora
Publikováno v:
Blood. 136:47-48
Introduction: Chronic Graft-versus-Host Disease (cGvHD) frequently requires prolonged immune suppressive therapy (IST) with > 50% still on IST at 5 years. The IST typically involves a slow taper of steroids often with flare of cGvHD, necessitating au
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b1464ddd657af735e96862f2d827652
https://doi.org/10.1182/blood-2020-136479
https://doi.org/10.1182/blood-2020-136479
Autor:
Margaret L. MacMillan, Takuto Takahashi, Mukta Arora, Daniel J. Weisdorf, Grigori Okoev, Todd E. DeFor
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S175-S176
Objectives Late acute graft-versus-host-disease (GVHD) in children is not well described. The 2014 NIH Chronic GVHD Consensus Criteria have not been studied in pediatric populations. We examined the incidence, organ involvement, severity by 2014 NIH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbfee76800e447cd269c70520804f891
https://doi.org/10.1016/j.bbmt.2019.12.733
https://doi.org/10.1016/j.bbmt.2019.12.733